Nirali S. Shah

h-index

Research activity per year

Headline

ASSISTANT PROFESSOR, Medicine, Endocrinology, Diabetes and Bone Disease

Fingerprint

Dive into the research topics where Nirali S. Shah is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

2 Article
1 Review article

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
Juszczak, A., Pavić, T., Vučković, F., Bennett, A. J., Shah, N., Medvidović, E. P., Groves, C. J., Šekerija, M., Chandler, K., Burrows, C., Putarek, N. R., Lovrenčić, M. V., Knežević, J. Ć., James, T. J., Gloyn, A. L., Lauc, G., McCarthy, M. I., Owen, K. R. & Gornik, O., 1 Jan 2019, In: Diabetes Care. 42, 1, p. 17-26 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
46 Scopus citations
Comparability of high-sensitivity CRP methods to detect maturity-onset diabetes of the young due to HNF1A mutations
Shah, N., Thanabalasingham, G., Owen, K. R. & James, T. J., 2014, In: British Journal of Biomedical Science. 71, 2, p. 84-85 2 p.
Research output: Contribution to journal › Review article › peer-review

5 Scopus citations
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes
Thanabalasingham, G., Shah, N., Vaxillaire, M., Hansen, T., Tuomi, T., Gašperíková, D., Szopa, M., Tjora, E., James, T. J., Kokko, P., Loiseleur, F., Andersson, E., Gaget, S., Isomaa, B., Nowak, N., Raeder, H., Stanik, J., Njolstad, P. R., Malecki, M. T. & Klimes, I. & 6 others, Groop, L., Pedersen, O., Froguel, P., McCarthy, M. I., Gloyn, A. L. & Owen, K. R., Nov 2011, In: Diabetologia. 54, 11, p. 2801-2810 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
102 Scopus citations

Study Findings on Mantle Cell Lymphoma Are Outlined in Reports from Oxford University Hospitals NHS Foundation Trust (Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma)
Shah, N. S.
7/10/24
1 item of Media coverage
Press/Media
Study Results from Oxford University Hospitals NHS Foundation Trust Update Understanding of Mantle Cell Lymphoma (Bruin Mcl-321: Phase Iii Study of Pirtobrutinib Versus Investigator Choice of Btk Inhibitor In Btk Inhibitor Naive Mantle Cell ...)
Shah, N. S.
21/12/22
1 item of Media coverage
Press/Media

Nirali S. Shah

Personal profile

Headline

Fingerprint

Research output

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes

Comparability of high-sensitivity CRP methods to detect maturity-onset diabetes of the young due to HNF1A mutations

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes

Press/Media

Study Findings on Mantle Cell Lymphoma Are Outlined in Reports from Oxford University Hospitals NHS Foundation Trust (Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma)

Study Results from Oxford University Hospitals NHS Foundation Trust Update Understanding of Mantle Cell Lymphoma (Bruin Mcl-321: Phase Iii Study of Pirtobrutinib Versus Investigator Choice of Btk Inhibitor In Btk Inhibitor Naive Mantle Cell ...)